Etiologies of Fever Among Adults in Dar es Salaam

Overview

Following the decline of malaria in Sub-Saharan Africa, clinicians face febrile patients in whom an alternative diagnosis has to be made. This situation has led to an overuse of antibiotics by clinicians. It is crucial to increase knowledge on etiologies and risk factors of outpatient febrile illness in order to improve their management. This present proposal aims to investigate the etiologies of fever among adult patients attending an outpatient department in urban Tanzania. It also aims to assess the clinical significance of nasopharyngeal (NP) respiratory viruses and bacteria documentation in this setting. Third, it aims to compare the spectrum of infections in this population with that of children included in the same setting in a previous study. The last objective is to assess diabetes mellitus (DM) as a risk factor for infection and exposure to indoor air pollution (IAP) as a risk factor for acute respiratory infections (ARI) in adults in Tanzania. The investigators hypothesize that acute respiratory infections are the main cause of adult febrile illness in a urban low-income setting and that use of quantitative molecular assays on naso-oropharyngeal samples can improve the diagnosis of pneumonia. The investigators also think that the spectrum of infections is different between children and adults, mainly due to a high HIV prevalence in adults. The investigators also hypothesize that experiencing IAP and/ or DM is a risk factor for infections in adults.

Full Title of Study: “Etiologies of Acute Febrile Illness Among Adults Attending an Outpatient Department in Dar es Salaam”

Study Type

  • Study Type: Observational [Patient Registry]
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: July 2014

Arms, Groups and Cohorts

  • Adults with fever
    • Every adult with fever will be screened for different infectious diseases and for nasopharyngeal respiratory viruses and bacteria
  • Healthy volonteers
    • For every adult with fever included with a diagnosis of pneumonia, a healthy volunteer will be included. These healthy volunteers will be screened for nasopharyngeal respiratory viruses and bacteria.

Clinical Trial Outcome Measures

Primary Measures

  • Proportion of patients with each disease among all febrile patients, overall and stratified by HIV status
    • Time Frame: 1 year
    • Description of the distribution of causes of fever based on pre-defined case definitions for each disease.

Secondary Measures

  • Proportion of febrile patients with acute respiratory infection infected with a certain respiratory pathogen, compared to the proportion of healthy controls infected with the same pathogen.
    • Time Frame: 1 year
    • Nasopharyngeal respiratory viruses and bacteria documentation (presence/absence as well as pathogen loads) will be compared between patients with acute respiratory infection and a control group of healthy volunteers

Participating in This Clinical Trial

Inclusion Criteria

  • Temperature >=38°C – History of fever for less than 8 days – First consultation for the present problem Exclusion Criteria:

  • Refusal of HIV screening – Main complaint is injury or trauma – Antibiotic treatment in the last 7 days – Within 6 weeks after delivery – Hospitalization during the last month

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Swiss Tropical & Public Health Institute
  • Collaborator
    • Ifakara Health Institute
  • Provider of Information About this Clinical Study
    • Principal Investigator: Valérie D’Acremont, Investigator – Swiss Tropical & Public Health Institute
  • Overall Official(s)
    • Valerie D’Acremont, MD PhD, Principal Investigator, Swiss Tropical & Public Health Institute

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.